122 reports of this reaction
2.0% of all DORZOLAMIDE HYDROCHLORIDE reports
#6 most reported adverse reaction
EYE IRRITATION is the #6 most commonly reported adverse reaction for DORZOLAMIDE HYDROCHLORIDE, manufactured by Micro Labs Limited. There are 122 FDA adverse event reports linking DORZOLAMIDE HYDROCHLORIDE to EYE IRRITATION. This represents approximately 2.0% of all 5,992 adverse event reports for this drug.
Patients taking DORZOLAMIDE HYDROCHLORIDE who experience eye irritation should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
EYE IRRITATION is a less commonly reported adverse event for DORZOLAMIDE HYDROCHLORIDE, but still significant enough to appear in the safety profile.
In addition to eye irritation, the following adverse reactions have been reported for DORZOLAMIDE HYDROCHLORIDE:
The following drugs have also been linked to eye irritation in FDA adverse event reports:
EYE IRRITATION has been reported as an adverse event in 122 FDA reports for DORZOLAMIDE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
EYE IRRITATION accounts for approximately 2.0% of all adverse event reports for DORZOLAMIDE HYDROCHLORIDE, making it a notable side effect.
If you experience eye irritation while taking DORZOLAMIDE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.